OSCR has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
OSCR has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.
Oscar Health's Sloan Ratio for the quarter that ended in Dec. 2024 was 8.98%.
As of Dec. 2024, Oscar Health has a Sloan Ratio of 8.98%, indicating the company is in the safe zone and there is no funny business with accruals.
The historical data trend for Oscar Health's Sloan Ratio % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Oscar Health Annual Data | |||||||||||||||
Trend | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | Dec24 | |||||||||
Sloan Ratio % | Get a 7-Day Free Trial | -12.54 | 11.55 | -16.79 | -15.99 | 8.98 |
Oscar Health Quarterly Data | ||||||||||||||||||||
Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | Dec24 | |
Sloan Ratio % | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
-15.99 | -3.22 | 2.39 | 6.34 | 8.98 |
For the Healthcare Plans subindustry, Oscar Health's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Healthcare Plans industry and Healthcare sector, Oscar Health's Sloan Ratio % distribution charts can be found below:
* The bar in red indicates where Oscar Health's Sloan Ratio % falls into.
Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.
Oscar Health's Sloan Ratio for the fiscal year that ended in Dec. 2024 is calculated as
Sloan Ratio | = | (Net Income (A: Dec. 2024 ) | - | Cash Flow from Operations (A: Dec. 2024 ) |
- | Cash Flow from Investing (A: Dec. 2024 )) | / | Total Assets (A: Dec. 2024 ) | |
= | (25.432 | - | 978.193 | |
- | -1387.434) | / | 4840.496 | |
= | 8.98% |
Oscar Health's Sloan Ratio for the quarter that ended in Dec. 2024 is calculated as
Sloan Ratio | = | (Net Income (TTM) | - | Cash Flow from Operations (TTM)) |
- | Cash Flow from Investing (TTM)) | / | Total Assets (Q: Dec. 2024 ) | |
= | (25.432 | - | 978.193 | |
- | -1387.434) | / | 4840.496 | |
= | 8.98% |
Oscar Health's Net Income for the trailing twelve months (TTM) ended in Dec. 2024 was 177.368 (Mar. 2024 ) + 56.207 (Jun. 2024 ) + -54.596 (Sep. 2024 ) + -153.547 (Dec. 2024 ) = $25 Mil. Oscar Health's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2024 was 634.363 (Mar. 2024 ) + 497.151 (Jun. 2024 ) + -500.141 (Sep. 2024 ) + 346.82 (Dec. 2024 ) = $978 Mil. Oscar Health's Cash Flow from Investing for the trailing twelve months (TTM) ended in Dec. 2024 was -300.589 (Mar. 2024 ) + -477.627 (Jun. 2024 ) + -577.77 (Sep. 2024 ) + -31.448 (Dec. 2024 ) = $-1,387 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Oscar Health (NYSE:OSCR) Sloan Ratio % Explanation
A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.
According to How to Beat the Market with the Sloan Ratio:
If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.
If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.
If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.
As of Dec. 2024, Oscar Health has a Sloan Ratio of 8.98%, indicating the company is in the safe zone and there is no funny business with accruals.
Thank you for viewing the detailed overview of Oscar Health's Sloan Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.
Alessandrea C. Quane | officer: EVP, Chief Insurance Officer | 175 WATER STREET, NEW YORK NY 10038 |
Richard Scott Blackley | officer: Chief Financial Officer | 1680 CAPITAL ONE DRIVE, MCLEAN VA 22102 |
Mario Schlosser | director, officer: Chief Executive Officer | C/O OSCAR HEALTH, INC., 75 VARICK STREET, 5TH FLOOR, NEW YORK NY 10013 |
Ranmali Bopitiya | officer: EVP & Chief Legal Officer | C/O OSCAR HEALTH, INC., 75 VARICK STREET, 5TH FLOOR, NEW YORK NY 10013 |
Victoria Baltrus | officer: Chief Accounting Officer | C/O OSCAR HEALTH, INC., 75 VARICK STREET, 5TH FLOOR, NEW YORK NY 10013 |
Joshua Kushner | director, 10 percent owner, officer: See Remarks | C/O OSCAR HEALTH, INC., 75 VARICK STREET, 5TH FLOOR, NEW YORK NY 10013 |
Thrive Partners Vii Growth Gp, Llc | 10 percent owner | 295 LAFAYETTE STREET, NEW YORK NY 10012 |
Robinson Elbert O. Jr. | director | C/O OSCAR HEALTH, INC., 75 VARICK STREET, 5TH FLOOR, NEW YORK NY 10013 |
Sid Sankaran | director, officer: Chief Financial Officer | 180 MAIDEN LANE, NEW YORK NY 10038 |
Alphabet Inc. | 10 percent owner | 1600 AMPHITHEATRE PARKWAY, MOUNTAIN VIEW CA 94043 |
Mark T Bertolini | director, officer: Chief Executive Officer | AETNA INC., 151 FARMINGTON AVENUE, HARTFORD CT 06156 |
William Gassen | director | 75 VARICK STREET, 5TH FLOOR, NEW YORK CITY NY 10013 |
Laura W Lang | director | DIGITAS INC., 800 BOYLSTON STREET, BOSTON MA 02199 |
Dennis Weaver | officer: Chief Clinical Officer | C/O OSCAR HEALTH, INC., 75 VARICK STREET, 5TH FLOOR, NEW YORK NY 10013 |
Meghan V. Joyce | officer: Chief Operating Officer | THE BOSTON BEER COMPANY, INC., ONE DESIGN CENTER PL., STE. 850, BOSTON MA 02210 |
From GuruFocus
By GuruFocus News • 12-04-2024
By GuruFocus News • 01-09-2025
By GuruFocus News • 02-27-2025
By GuruFocus News • 01-06-2025
By GuruFocus News • 12-11-2024
By GuruFocus News • 02-03-2025
By GuruFocus News • 02-04-2025
By GuruFocus News • 02-14-2025
By GuruFocus News • 01-22-2025
By GuruFocus News • 12-06-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.